TrialNet In the News
The Indy Channel (Indianapolis, IN), February 2008:
Frank is enrolled in the Type 1 Diabetes TrialNet study because his sister has the disease. In this blind study, participants receive baby formula with three times the regular amount of a supplement called docosahexaenoic acid, or DHA. It's an omega-3 fatty acid found in fish, walnuts and soybean.
Review of Endocrinology, January 2008:
Direct Link to Article (pdf)
The Most Important Piece of the Puzzle in Curing Diabetes Is You
ABC7 (San Francisco), January 2008:
Doctors at UCSF are investigating an unusual approach to prevent type one diabetes. They want to see if adding a certain dietary intervention in the first months of life could prevent a child's body from turning on itself and developing diabetes.
When a child is diagnosed with juvenile diabetes, also known as Type 1 diabetes, the most serious form of the disease, routines and priorities change.
Pittsburgh Tribune-Review, November 2007:
Safety trials of a medical technique that could reverse Type 1 diabetes might be completed by year's end at Children's Hospital of Pittsburgh, the lead researcher told diabetes experts gathered Wednesday in Miami.
WBAL-11 TV (Baltimore, MD), November 2007:
(Video)
Diabetes is a growing epidemic, and while some children don't have diabetes, they are predisposed to it. Doctors are hoping a new pill can help those patients.
KOMORadio (Seattle, WA), November 2007:
(Audio)
Corwin Haeck reports a 10 year old girl with diabetes is teaming up with her little brother to help prevent the juvenile form of the disease.
NBC6 (South Florida), November 2007:
(Video)
Researchers at the University of Miami are studying a new treatment that could better maintain type 1 diabetes.
Approximately 85,000 people in El Paso have diabetes, according to the El Paso Diabetes Association.
Because of El Paso's high incidence of diabetes, the county has been chosen to participate in a National Institutes of Health-funded study. The focus of the study, known as Type 1 Diabetes TrialNet, will be on detecting which relatives of people who have Type 1 diabetes might develop the disease.
NewsChannel5 (Nashville, TN), September 2007:
(Video)
"There are not many diseases like this where you have the hope of actually preventing them from happening," said Dave Gould, the parents of three kids with type 1 diabetes.
In type 1 diabetes, a person's own immune system destroys the cells in the pancreas that produce insulin. Having a close family member with the disease makes a person ten-times more likely to develop it.
Now, researchers are focusing on those at high-risk and testing a new way to prevent the disease from ever happening.
Now, for the first time, Indiana University researchers are turning to a cancer drug called rituximab to see if it can increase insulin production. Researchers are testing the cancer drug on recently diagnosed type-one diabetes patients who are at least eight years old.
[T]he Mahoneys are attempting to halt the disease before it starts. They've joined a study with Boston's Joslin Diabetes Center examining the possibly preventative role that Omega-3 fatty acids -- also called docosahexaenoic acid, or DHA -- might play in the development of type 1 diabetes.
Denver Post, 25 February 2007:
The Davis Center, part of the University of Colorado Health Sciences Center, is one of dozens of sites around the world trying to find out whether regular doses of oral insulin can stop a strong propensity for diabetes from turning into the disease.
NIH Press Release, 31 January 2007:
Researchers have begun a clinical study of oral insulin to prevent or delay type 1 diabetes in at-risk people, the National Institutes of Health (NIH) announced today. Type 1 Diabetes TrialNet, an NIH-funded network of researchers dedicated to the understanding, prevention, and early treatment of type 1 diabetes, is conducting the study in more than 100 medical centers across the United States, Canada, Europe, and Australia.
Type 1 diabetes has a formidable new enemy: A global network of diabetes researchers, immunology experts, and specialized laboratories and facilities is pooling resources to understand—and hopefully prevent—type 1 diabetes.
Researchers to screen relatives for type 1 diabetes risk factors
Eighteen medical centers in the United States, Canada, Europe and Australia are participating in Type 1 Diabetes TrialNet...
Full text of article not available online.
Penn State Diabetes Center Research Newsletter (Vol. 1, No. 2, 2005):
This research study is ongoing at many centers around the world and screens relatives of people with type 1 diabetes to see if they are also at risk. If you have type 1 diabetes, do you want to know if your children are at risk? Does your sibling or cousin have type 1 diabetes and do you worry that you may be next? Then this study may be for you. And, in the near future, this study will include experimental diabetes prevention treatments as well.